Published in Vaccine on June 02, 2006
Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers (Girasol) | NCT00925288
Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst (2011) 4.59
Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis (2008) 3.19
Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women. J Low Genit Tract Dis (2010) 2.03
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy. J Control Release (2015) 1.55
Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol (2009) 1.45
Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev (2010) 1.36
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med (2011) 1.23
HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa. Epidemics (2010) 1.22
Genital HPV infection and related lesions in men. Prev Med (2011) 1.19
Detection of genital HPV types in fingertip samples from newly sexually active female university students. Cancer Epidemiol Biomarkers Prev (2010) 1.18
Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals. J Infect Dis (2013) 1.17
Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis (2009) 1.15
Papillomaviruses: Viral evolution, cancer and evolutionary medicine. Evol Med Public Health (2015) 1.13
Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study. BMC Infect Dis (2011) 1.11
The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. BMC Infect Dis (2011) 1.06
Prevalence of high-risk human papillomavirus among older women. Obstet Gynecol (2008) 1.01
Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study. BMC Infect Dis (2008) 1.01
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies. BMC Public Health (2012) 1.01
A modeling framework for the analysis of HPV incidence and persistence: a semi-parametric approach for clustered binary longitudinal data analysis. Stat Med (2010) 1.01
Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry. Fam Cancer (2010) 0.99
A school-based human papillomavirus vaccination program in barretos, Brazil: final results of a demonstrative study. PLoS One (2013) 0.97
Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women. Sex Transm Dis (2012) 0.96
Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sex Transm Dis (2009) 0.96
Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women. J Clin Microbiol (2007) 0.92
New insights into cervical cancer screening. J Gynecol Oncol (2012) 0.92
Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. J Infect Dis (2012) 0.91
Human papillomaviruses as therapeutic targets in human cancer. J Clin Oncol (2011) 0.90
Age of diagnosis of squamous cell cervical carcinoma and early sexual experience. Cancer Epidemiol Biomarkers Prev (2009) 0.90
Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women. Int J Cancer (2013) 0.89
Human papillomavirus vaccination in survivors of childhood cancer. Cancer (2009) 0.89
Human papillomavirus: the usefulness of risk factors in determining who should get vaccinated. Rev Obstet Gynecol (2008) 0.89
Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women. Sex Transm Dis (2009) 0.87
Characterisation of human papillomavirus (HPV) genotypes in the Azorean population, Terceira island. Infect Agent Cancer (2008) 0.87
HPV prevalence among women from Appalachia: results from the CARE project. PLoS One (2013) 0.86
Survey of human papillomavirus types and their vertical transmission in pregnant women. BMC Infect Dis (2013) 0.85
Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents. J Adolesc Health (2008) 0.85
Sexually related behaviors as predictors of HPV vaccination among young rural women. J Womens Health (Larchmt) (2011) 0.84
Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years. J Infect Dis (2016) 0.84
Evolution of human papillomavirus carcinogenicity. Adv Virus Res (2010) 0.83
Measuring cervical cancer risk: development and validation of the CARE Risky Sexual Behavior Index. Cancer Causes Control (2009) 0.83
Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study. BMC Infect Dis (2012) 0.83
Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly. Int J Cancer (2015) 0.83
Human papillomavirus vaccines launch a new era in cervical cancer prevention. CMAJ (2007) 0.83
Viral carcinogenesis: factors inducing DNA damage and virus integration. Cancers (Basel) (2014) 0.82
Human papillomavirus detection in cervical scrapes from women attended in the Family Health Program. Rev Lat Am Enfermagem (2014) 0.82
Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus. Biomed Res Int (2013) 0.81
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil). Ther Clin Risk Manag (2008) 0.81
Cervical Cytology and Human Papillomavirus Testing in Adolescent Women: Implications in Management of a Positive HPV Test. Patholog Res Int (2014) 0.80
Human papillomavirus disease and vaccines in adolescents. Adolesc Med State Art Rev (2010) 0.80
The role of family history of cancer on cervical cancer screening behavior in a population-based survey of women in the Southeastern United States. Womens Health Issues (2013) 0.80
Oncogenic Human Papillomavirus Infections in 18- to 24-Year-Old Female Online Daters. Sex Transm Dis (2015) 0.78
Anti-tumor effects of genetic vaccines against HPV major oncogenes. Hum Vaccin Immunother (2014) 0.78
Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women. Int J Cancer (2012) 0.78
Rome Consensus Conference - statement; human papilloma virus diseases in males. BMC Public Health (2013) 0.77
Conservative management of adolescents with abnormal cytology and histology. J Natl Compr Canc Netw (2008) 0.77
Natural history of histologically moderate cervical dysplasia in adolescent and young women. Onco Targets Ther (2014) 0.77
Oral vs. Vaginal Sex Experiences and Consequences Among First-Year College Students. Arch Sex Behav (2015) 0.77
Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infection. Sex Transm Dis (2009) 0.76
Are the currently existing anti-human papillomavirus vaccines appropriate for the developing world? Ann Med Health Sci Res (2013) 0.76
The impact of HPV female immunization in Italy: model based predictions. PLoS One (2014) 0.76
Impact of HPV vaccination on anogenital warts and respiratory papillomatosis. Hum Vaccin Immunother (2016) 0.75
Human Papillomavirus (HPV) Infections and the Importance of HPV Vaccination. Curr Epidemiol Rep (2015) 0.75
Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study. BMC Infect Dis (2016) 0.75
HPV genotype distribution and anomalous association of HPV33 to cervical neoplastic lesions in San Luis Potosí, Mexico. Infect Agent Cancer (2016) 0.75
Vaccine knowledge in students in Paris, France, and surrounding regions. Can J Infect Dis Med Microbiol (2014) 0.75
Concurrent Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx in a Married Couple. Case Rep Otolaryngol (2016) 0.75
A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica. BMC Infect Dis (2013) 0.75
Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria. Pan Afr Med J (2016) 0.75
Epidemiology of Human Papillomavirus Detected in the Oral Cavity and Fingernails of Mid-Adult Women. Sex Transm Dis (2015) 0.75
Trends in Cervical Cancer Among Delivery-Related Discharges and its Impact on Maternal-Infant Birth Outcomes (United States, 1998-2009). Open Nurs J (2015) 0.75
The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model. PLoS One (2015) 0.75
Analysis of longitudinal multivariate outcome data from couples cohort studies: application to HPV transmission dynamics. J Am Stat Assoc (2015) 0.75
Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women. Virol J (2017) 0.75
The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer (2016) 0.75
Rapid acquisition of HPV around the time of sexual debut in adolescent girls in Tanzania. Int J Epidemiol (2016) 0.75
Factors associated with HPV vaccination among adult women in Quebec. Hum Vaccin Immunother (2013) 0.75
Anogenital warts in Northern Nigeria: A ten-year Review. Niger Med J (2013) 0.75
Is "Sexual Competence" at First Heterosexual Intercourse Associated With Subsequent Sexual Health Status? J Sex Res (2016) 0.75
Differences in age-specific HPV prevalence between self-collected and health personnel collected specimen in a cross-sectional study in Ghana. Infect Agent Cancer (2017) 0.75
INCIDENCE AND RISK FACTORS FOR HUMAN PAPILLOMAVIRUS INFECTIONS IN YOUNG FEMALE ONLINE DATERS. J Med Virol (2017) 0.75
Causal role of infectious agents in cancer: An overview. Caspian J Intern Med (2017) 0.75
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
International network of cancer genome projects. Nature (2010) 20.35
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med (2007) 9.53
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (2004) 8.09
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin (2012) 5.58
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis (2010) 4.42
Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr (2003) 4.35
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst (2006) 4.14
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis. J Natl Cancer Inst (2012) 3.87
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer (2009) 3.64
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol (2012) 3.51
Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis (2007) 3.48
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38
Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer (2012) 3.35
The epidemiology of genital human papillomavirus infection. Vaccine (2006) 3.28
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2012) 3.25
Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis (2011) 3.16
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis (2012) 3.15
Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol (2007) 2.90
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev (2003) 2.52
Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol (2011) 2.52
Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol (2007) 2.49
Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev (2006) 2.39
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med (2007) 2.35
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine (2006) 2.25
Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol (2008) 2.00
Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study. Cancer Causes Control (2003) 2.00
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst (2012) 1.99
Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatr Blood Cancer (2008) 1.98
HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis (2011) 1.95
Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis (2009) 1.89
Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med (2011) 1.89
Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst (2003) 1.84
The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers (2007) 1.83
Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer (2003) 1.78
Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev (2006) 1.77
Risk factors of invasive cervical cancer in Mali. Int J Epidemiol (2002) 1.74
Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis (2008) 1.72
Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine (2007) 1.71
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer (2012) 1.69
Management of low-grade cervical lesions in young women. CMAJ (2005) 1.69
Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis. Int J Cancer (2010) 1.65
Assessing the gain in diagnostic performance when combining two diagnostic tests. Stat Med (2002) 1.65
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer (2012) 1.63
Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine (2012) 1.58
From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis (2008) 1.58
Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health (2007) 1.53
Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol (2006) 1.53
Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res (2010) 1.50
NT-proBNP: a cardiac biomarker to assess prognosis in non-Hodgkin lymphoma. Leuk Res (2011) 1.44
Diagnosis delays in childhood cancer: a review. Cancer (2007) 1.44
Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev (2007) 1.43
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer (2014) 1.40
Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis (2012) 1.38
Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev (2006) 1.34
Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol (2007) 1.34
Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol (2004) 1.34
Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men. Am J Epidemiol (2005) 1.33
Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomarkers Prev (2005) 1.32
Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev (2003) 1.31
Making prospective registration of observational research a reality. Sci Transl Med (2014) 1.31
p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev (2004) 1.26
Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction (2004) 1.26
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer (2012) 1.23
A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine (2012) 1.22
Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer (2006) 1.22
Human papillomavirus infections among couples in new sexual relationships. Epidemiology (2010) 1.20
Human papillomavirus in cervical cancer. Curr Oncol Rep (2002) 1.19
Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev (2010) 1.16
Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis (2009) 1.15
Genital transmission of human papillomavirus in recently formed heterosexual couples. J Infect Dis (2011) 1.15
Exposure to ultraviolet radiation and risk of malignant lymphoma and multiple myeloma--a multicentre European case-control study. Int J Epidemiol (2008) 1.15
Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiol Biomarkers Prev (2008) 1.14
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer Res (2008) 1.13
Human Papillomavirus type distribution in invasive cervical cancer in Uganda. BMC Infect Dis (2008) 1.12
Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine (2012) 1.12
Burden of disease, health indicators and challenges for epidemiology in North America. Int J Epidemiol (2012) 1.12
Report of the 2003 pan-Canadian forum on cervical cancer prevention and control. J Obstet Gynaecol Can (2004) 1.09
Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. Am J Epidemiol (2013) 1.09
Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students. J Infect Dis (2008) 1.09
Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Am J Manag Care (2006) 1.08
Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study. PLoS One (2011) 1.07
A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC Cancer (2010) 1.07
Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis (2006) 1.07
Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy. Vaccine (2012) 1.06
Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention. Int J Cancer (2008) 1.05
Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix. J Clin Microbiol (2012) 1.05
Serum antibody response following genital {alpha}9 human papillomavirus infection in young men. J Infect Dis (2011) 1.05
Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women. Cancer Epidemiol Biomarkers Prev (2009) 1.03
Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.02
The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol (2010) 1.01
Lymphoma risk and occupational exposure to pesticides: results of the Epilymph study. Occup Environ Med (2012) 1.01
Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study. J Infect Dis (2003) 1.01